SINTX Announces Milestones In The Development and Testing of Antipathogenic Fabrics
February 23 2022 - 9:00AM
SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) (“SINTX” or
the “Company”), an original equipment manufacturer (OEM) of
advanced ceramics, announced new results on the development of
manufacturing technologies to produce fabrics impregnated with
SINTX silicon nitride, and the antipathogenic testing of these
fabrics.
SINTX has previously announced a collaboration
to develop large-scale fabric impregnation technology with a
private company based in Europe. The antibacterial properties of
silicon nitride embedded fabric produced from this “dry” process
were recently tested at an accredited independent commercial
laboratory. The lab used ASTM and AATCC protocols and found that
this silicon nitride embedded fabric inactivated Staphylococcus
Aureus in both protocols.
Development of a manufacturing process has also
continued via the utilization of the new“pre-pilot line” equipment
and “wet” impregnation process at SINTX’s internal research and
development laboratory. The most recent silicon nitride embedded
fabric made from this process was tested against SARS-CoV-2 and was
found to inactivate the virus with greater efficiency than fabric
produced and tested previously. Since the testing occurred at a
different high profile academic institution, these results also
mark the first independent validation of the antiviral fabric
properties observed at the University of Rochester. SINTX’s
investments in new equipment and process development are yielding
improved results.
SINTX considers these antipathogenic test
results significant - two different silicon nitride impregnation
processes were tested at two different independent laboratories
using standard protocols. These are compelling milestones in the
Company’s progress in developing antipathogenic fabrics that can be
leveraged across different applications such as medical gowns,
consumer facemasks, and more.
About SINTX Technologies, Inc.
SINTX Technologies is an OEM ceramics company
that develops and commercializes advanced ceramics for medical and
non-medical applications including armor. The core strength of
SINTX Technologies is the manufacturing, research, and development
of ceramics for external partners. The Company presently
manufactures silicon nitride materials and components in its FDA
registered, ISO 13485:2016 certified, and ASD9100D certified
manufacturing facility in Salt Lake City, Utah.
For more information on SINTX Technologies
or its advanced ceramics material platforms, please
visit www.sintx.com.
Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995 (PSLRA) that are subject to a number of risks
and uncertainties. Risks and uncertainties that may cause such
differences to include, among other things: our products may not
prove to be as effective as other products currently being
commercialized or to be commercialized in the future by
competitors; risks inherent in manufacturing and scaling up to
commercial quantities while maintaining quality controls;
volatility in the price of SINTX’s common stock; the uncertainties
inherent in new product development, including the cost and time
required to commercialize such product(s); market acceptance of our
products once commercialized; SINTX’s ability to raise funding and
other competitive developments. Readers are cautioned not to place
undue reliance on the forward-looking statements, which speak only
as of the date on which they are made and reflect management’s
current estimates, projections, expectations, and beliefs. There
can be no assurance that any of the anticipated results will occur
on a timely basis or at all due to certain risks and uncertainties,
a discussion of which can be found in SINTX’s Risk Factors
disclosure in its Annual Report on Form 10-K, filed with the
Securities and Exchange Commission (SEC) on March 22, 2021, and in
SINTX’s other filings with the SEC. SINTX undertakes no obligation
to publicly revise or update the forward-looking statements to
reflect events or circumstances that arise after the date of this
report.
Business Inquiries for SINTX:SINTX
Technologies801.839.3502IR@sintx.com
Media Inquiries for SINTX: Amanda Barry
Director of Content & PR The Summit Group
abarry@summitslc.com
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Mar 2024 to Apr 2024
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Apr 2023 to Apr 2024